These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9703171)

  • 21. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.
    Solimena M; De Camilli P
    Trends Neurosci; 1991 Oct; 14(10):452-7. PubMed ID: 1722364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy.
    Muhr D; Mollenhauer U; Ziegler AG; Haslbeck M; Standl E; Schnell O
    Diabetes Care; 1997 Jun; 20(6):1009-12. PubMed ID: 9167116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
    Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
    Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
    Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
    Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.
    Butler MH; Solimena M; Dirkx R; Hayday A; De Camilli P
    J Exp Med; 1993 Dec; 178(6):2097-106. PubMed ID: 8245784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
    Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
    Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
    Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.
    Kallmann BA; Hüther M; Tubes M; Feldkamp J; Bertrams J; Gries FA; Lampeter EF; Kolb H
    Diabetes; 1997 Feb; 46(2):237-43. PubMed ID: 9000700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between humoral and cellular immunity to IA-2 in IDDM.
    Ellis TM; Schatz DA; Ottendorfer EW; Lan MS; Wasserfall C; Salisbury PJ; She JX; Notkins AL; Maclaren NK; Atkinson MA
    Diabetes; 1998 Apr; 47(4):566-9. PubMed ID: 9568688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral and cellular autoimmune responses in stiff person syndrome.
    Lohmann T; Londei M; Hawa M; Leslie RD
    Ann N Y Acad Sci; 2003 Sep; 998():215-22. PubMed ID: 14592879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
    Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
    Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents.
    Honeyman MC; Stone NL; Harrison LC
    Mol Med; 1998 Apr; 4(4):231-9. PubMed ID: 9606176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.